Skip to main content
. 2014 Nov 1;6(5):1178–1189. doi: 10.4161/mabs.32114

Figure 1.

Figure 1.

Support of a global filing strategy results in a complex comparative analysis of multiple products. The development studies are designed to compare the biosimilar product to reference product acquired in different regions, and to support a scientific bridge comparing the reference products.